Specialty drugs are one of the fastest-growing costs for self-insured employers, with prices expected to continue to rise 8% annually through 2025.
We are the only navigation solution proven to combat this alarming trend as part of our core service. Our independent, unbiased clinical review and approval process ensures the most cost-effective, clinically appropriate treatments administered at the right site of care.
The results are remarkable:
- 48% average savings per dose or administration with every site-of-care shift
- 91% success rate when recommending more cost-effective, clinically appropriate injection or infusion sites
- $2.08 average savings per member, per month
